Skip to main content
OTCMKTS:IPAH

Interpharm Stock Forecast, Price & News

$0.0005
0.00 (0.00 %)
(As of 05/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
$0.00
VolumeN/A
Average Volume33,470 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta3.28
30 days | 90 days | 365 days | Advanced Chart
Receive IPAH News and Ratings via Email

Sign-up to receive the latest news and ratings for Interpharm and its competitors with MarketBeat's FREE daily newsletter.


About Interpharm

Interpharm Holdings, Inc. engages in the development, manufacture and distribution of pharmaceutical products. The company was founded on July 17, 1992 and is headquartered in Hauppauge, NY.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:IPAH
CUSIPN/A
CIKN/A
Phone(631) 952-0214
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.17 out of 5 stars

Medical Sector

1838th out of 2,042 stocks

Pharmaceutical Preparations Industry

727th out of 770 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Interpharm (OTCMKTS:IPAH) Frequently Asked Questions

What stocks does MarketBeat like better than Interpharm?

Wall Street analysts have given Interpharm a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Interpharm wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Interpharm's key competitors?

What is Interpharm's stock symbol?

Interpharm trades on the OTCMKTS under the ticker symbol "IPAH."

How do I buy shares of Interpharm?

Shares of IPAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Interpharm's stock price today?

One share of IPAH stock can currently be purchased for approximately $0.00.

What is Interpharm's official website?

The official website for Interpharm is www.interpharminc.com.

Where are Interpharm's headquarters?

Interpharm is headquartered at 75 ADAMS AVENUE, HAUPPAGUE NY, .

How can I contact Interpharm?

Interpharm's mailing address is 75 ADAMS AVENUE, HAUPPAGUE NY, . The company can be reached via phone at (631) 952-0214 or via email at [email protected]


This page was last updated on 5/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.